Friday, 19 April 2024

 

 

LATEST NEWS CGC Jhanjeri’s Fashion Show MERAKI 2024 goes in Style CEO Maneesh Garg briefs about Postal ballot facility for absentee voters Alumnus Sh. Ram Kumar Mittal, Founder & President of Swami International, USA, Inspires Students During Campus Visit to PEC In a first, CEO Sibin C holds Facebook live interaction with Punjab voters Top 9 Monalisa Hot Web Series To Watch In April 2024 | 5 Dariya News Drug awareness rally under NSS camp by RBU students Wheat planted using surface feeders at 40 places in barnala district : Punamdeep Kaur NSS PEC Organized Blood Donation Camp in Collaboration with PGIMER Biomed lab science day celebrated at RBU Singer Javed Ali recorded the song for Speed India Entertainment & HGV Anup Jalota, Udit Narayan, Babul Supriyo, and other singers received Dr. K.J. Yesudas Achievement Award Unique Initiative: Punjab's CEO Sibin C to go live on Facebook on April 19th Special monitoring of Social Media for Model Code of Conduct compliance - Chief Electoral Officer Anurag Agarwal In unique initiative, administration launches video helpline number 83605-83697 for speech and hearing-impaired voters Sakshi Sawhney directs procurement agencies to expedite wheat lifting Will make Punjabi the number one language in Chandigarh - Sanjay Tandon Vigilance Bureau nabs ASI for accepting Rs 4,500 bribe Magnificent Display of Indian Culture at LPU's annual 'One India-2024' Cultural Fest Suzuki Motorcycle India expands its footprint in Kerala Unlike Ravneet Bittu, Congress Has Always Respected Beant Singh Ji’s Legacy: Amarinder Singh Raja Warring Kunwar Vijay Pratap's speech should be taken seriously and investigation should be conducted: Partap Singh Bajwa

 

Hybrid immunity best protection against Covid-19 : Researchers

XE variant, Omicron Variant, Delta Plus Covid variant, Delta Covid-19 variant, Coronavirus, Health, Research, Study, Researchers, COVID 19, Novel Coronavirus, Fight Against Corona, Covaxin, Covishield, Oxygen, SARS-CoV-2, Sputnik V, Oxygen Plants, Pfizer, Astra Zeneca, Oxygen Concentrator, Remdesivir, Liquid Medical Oxygen, Oximeter
Listen to this article

Web Admin

Web Admin

5 Dariya News

Toronto , 22 Jan 2023

People with hybrid immunity are the most protected against severe illness and reinfection, a new study has found. Results from global data show vaccination and a prior Covid-19 infection offer the best defence against severe illness and reinfection, according to a University of Calgary research group.

Hybrid immunity occurs when someone has had at least the full series of vaccines and has a prior infection, in any order. The study published in The Lancet Infectious Diseases will help public policy makers understand the optimal timing of vaccinations.

"The results reinforce the global imperative for vaccination. A common question throughout the pandemic was whether previously infected people should also get vaccinated. 

Our results clearly indicate the need for vaccination, even among people who have had Covid-19," said Dr Niklas Bobrovitz, first author on the study. 

In the study, investigators were able to look at immune protection against Omicron after a prior SARS-CoV-2 infection (the virus that causes Covid-19), vaccination, or hybrid immunity.

"Protection against hospitalization and severe disease remained above 95 per cent for 12 months for individuals with hybrid immunity," said Dr Lorenzo Subissi, WHO-Scientist and senior author on the study.

The systematic review and meta-analysis find that protection against Omicron infection declines substantially by 12 months, regardless of whether you've had an infection, vaccinations, or both.

It means that vaccination is the best way to periodically boost your protection and to keep down levels of infection in the population. While the findings demonstrate that vaccination along with a prior infection carries the most protection, the scientists warn against intentional exposure to the virus.

"You should never try to get Covid-19," said Bobrovitz. "The virus is unpredictable in how it will affect your system. For some, it can be fatal or send you to hospital. Even if you have a mild infection, you risk developing a long Covid."

 

Tags: XE variant , Omicron Variant , Delta Plus Covid variant , Delta Covid-19 variant , Coronavirus , Health , Research , Study , Researchers , COVID 19 , Novel Coronavirus , Fight Against Corona , Covaxin , Covishield , Oxygen , SARS-CoV-2 , Sputnik V , Oxygen Plants , Pfizer , Astra Zeneca , Oxygen Concentrator , Remdesivir , Liquid Medical Oxygen , Oximeter

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2024 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD